| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 3,357,367 | 4,634,086 | 4,343,675 | | Cost of Revenue | 1,152,024 | 1,273,986 | 1,196,019 | | | Gross Profit | 2,205,343 | 3,360,100 | 3,147,656 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,530,065 | 2,101,653 | 2,050,948 | | Non Recurring | 1,307,970 | 151,000 |
-
| | Others | 36,488 | 57,271 | 68,410 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (669,180) | 1,050,176 | 1,028,298 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,336,212) | (523,624) | 87,030 | | Earnings Before Interest And Taxes | (3,005,392) | 526,552 | 1,115,328 | | Interest Expense | 150,465 | 82,681 | 71,474 | | Income Before Tax | (3,155,857) | 443,871 | 1,043,854 | | Income Tax Expense | (1,210,853) | 175,995 | 397,612 | | Minority Interest | (2,924) | (266) | 4 | | | | Net Income From Continuing Ops | (1,947,928) | 267,610 | 646,246 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 572 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,947,928) | 267,610 | 646,818 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,947,928) | $267,610 | $646,818 |
|
1.48% Nasdaq 
Income Statement
